1 asset in Generalized Lipodystrophy
Therapeutic assets addressing Generalized Lipodystrophy, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Mibavademab Generalized Lipodystrophy | Regeneron Pharmaceuticals | P3 | NR () |